Quantitative Neuroproteomics: Classical and Novel Tools for Studying Neural Differentiation and Function

Stem Cell Reviews and Reports

Volumn 7, Issue 1, 2011, Pages 77-93

  Colucci D'Amato, Luca ^a,b   Farina, Annarita ^c   Vissers, Johannes P C ^d   Chambery, Angela ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d WATERS CORPORATION   (United States)

Author keywords

2DE (2D PAGE); Isotopic labeling; Label free; LC MS; MALDI TOF; Mass spectrometry; Neural differentiation; Neurodegeneration; Neuroproteomics; Proteomic profiling

Indexed keywords

EID: 78751643723     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9136-3     Document Type: Review

References (127)

1. Schurov, I. L., Handford, E. J., Brandon, N. J., & Whiting, P. J. (2004). Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Molecular Psychiatry, 9, 1100-1110.
2. Dranovsky, A., & Hen, R. (2007). DISC1 puts the brakes on neurogenesis. Cell, 130, 981-983.
3. Mackie, S., Millar, J. K., & Porteous, D. J. (2007). Role of DISC1 in neural development and schizophrenia. Current Opinion in Neurobiology, 17, 95-102.
4. Leo, D., Sorrentino, E., Volpicelli, F., et al. (2003). Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD. Neuroscience and Biobehavioral Reviews, 27, 661-669.
5. Pouget, P., Wattiez, N., Rivaud-Pechoux, S., & Gaymard, B. (2009). A fragile balance: Perturbation of GABA mediated circuit in prefrontal cortex generates high intraindividual performance variability. PLoS ONE, 4, e5208.
6. Calegari, F., & Huttner, W. B. (2003). An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. Journal of Cell Science, 116, 4947-4955.
7. Wang, W., Bu, B., Xie, M., Zhang, M., Yu, Z., & Tao, D. (2009). Neural cell cycle dysregulation and central nervous system diseases. Progress in Neurobiology, 89, 1-17.
8. Greene, L. A., & Tischler, A. S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America, 73, 2424-2428.
9. Huang, E. J., & Reichardt, L. F. (2001). Neurotrophins: Roles in neuronal development and function. Annual Review of Neuroscience, 24, 677-736.
10. Aebersold, R., Rist, B., & Gygi, S. P. (2000). Quantitative proteome analysis: Methods and applications. Annals of the New York Academy of Sciences, 919, 33-47.
11. Gygi, S. P., & Aebersold, R. (2000). Mass spectrometry and proteomics. Current Opinion in Chemical Biology, 4, 489-494.
12. Hoffrogge, R., Beyer, S., Volker, U., Uhrmacher, A. M., & Rolfs, A. (2006). 2-DE proteomic profiling of neuronal stem cells. Neuro-degenerative Diseases, 3, 112-121.
13. Bottcher, T., Mix, E., Koczan, D., et al. (2003). Gene expression profiling of ciliary neurotrophic factor-overexpressing rat striatal progenitor cells (ST14A) indicates improved stress response during the early stage of differentiation. Journal of Neuroscience Research, 73, 42-53.
14. Kwak, D. H., Yu, K., Kim, S. M., et al. (2006). Dynamic changes of gangliosides expression during the differentiation of embryonic and mesenchymal stem cells into neural cells. Experimental and Molecular Medicine, 38, 668-676.
15. Gygi, S. P., Rochon, Y., Franza, B. R., & Aebersold, R. (1999). Correlation between protein and mRNA abundance in yeast. Molecular and Cellular Biology, 19, 1720-1730.
16. Becker, M., Schindler, J., & Nothwang, H. G. (2006). Neuroproteomics- - the tasks lying ahead. Electrophoresis, 27, 2819-2829.
17. Andrade, E. C., Krueger, D. D., & Nairn, A. C. (2007). Recent advances in neuroproteomics. Current Opinion in Molecular Therapeutics, 9, 270-281.
18. Beyer, S., Mix, E., Hoffrogge, R., Lünser, K., Völker, U., & Rolfs, A. (2007). Neuroproteomics in stem cell differentiation. Proteomics Clinical Applications, 1, 1513-1523.
19. Butcher, J. (2007). Neuroproteomics comes of age. Lancet Neurology, 6, 850-851.
20. Maurer, M. H., Feldmann, R. E., Jr., Futterer, C. D., & Kuschinsky, W. (2003). The proteome of neural stem cells from adult rat hippocampus. Proteome Science, 1, 4.
21. Maurer, M. H., Feldmann, R. E., Jr., Futterer, C. D., Butlin, J., & Kuschinsky, W. (2004). Comprehensive proteome expression profiling of undifferentiated versus differentiated neural stem cells from adult rat hippocampus. Neurochemical Research, 29, 1129-1144.
22. Dahl, A., Eriksson, P. S., Persson, A. I., et al. (2003). Proteome analysis of conditioned medium from cultured adult hippocampal progenitors. Rapid Communications in Mass Spectrometry, 17, 2195-2202.
23. Ianora, A., Miralto, A., Poulet, S. A., et al. (2004). Aldehyde suppression of copepod recruitment in blooms of a ubiquitous planktonic diatom. Nature, 429, 403-407.
24. Di Lieto, A., Leo, D., Volpicelli, F., di Porzio, U., & Colucci-D'Amato, L. (2007). FLUOXETINE modifies the expression of serotonergic markers in a differentiation-dependent fashion in the mesencephalic neural cell line A1 mes c-myc. Brain Research, 1143, 1-10.
25. Baharvand, H., Hajheidari, M., Ashtiani, S. K., & Salekdeh, G. H. (2006). Proteomic signature of human embryonic stem cells. Proteomics, 6, 3544-3549.
26. Baharvand, H., Hajheidari, M., Zonouzi, R., Ashtiani, S. K., Hosseinkhani, S., & Salekdeh, G. H. (2006). Comparative proteomic analysis of mouse embryonic stem cells and neonatal-derived cardiomyocytes. Biochemical and Biophysical Research Communications, 349, 1041-1049.
27. Hoffrogge, R., Mikkat, S., Scharf, C., et al. (2006). 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics, 6, 1833-1847.
28. Hoffrogge, R., Beyer, S., Hubner, R., et al. (2007). 2-DE profiling of GDNF overexpression-related proteome changes in differentiating ST14A rat progenitor cells. Proteomics, 7, 33-46.
29. An, J., Yuan, Q., Wang, C., et al. (2005). Differential display of proteins involved in the neural differentiation of mouse embryonic carcinoma P19 cells by comparative proteomic analysis. Proteomics, 5, 1656-1668.
30. Inberg, A., Bogoch, Y., Bledi, Y., & Linial, M. (2007). Cellular processes underlying maturation of P19 neurons: Changes in protein folding regimen and cytoskeleton organization. Proteomics, 7, 910-920.
31. Chambery, A., Colucci-D'Amato, L., Vissers, J. P., Scarpella, S., Langridge, J. I., & Parente, A. (2009). Proteomic profiling of proliferating and differentiated neural mes-c-myc A1 cell line from mouse embryonic mesencephalon by LC-MS. Journal of Proteome Research, 8, 227-238.
32. Colucci-D'Amato, G. L., Tino, A., Pernas-Alonso, R., ffrench-Mullen, J. M., & di Porzio, U. (1999). Neuronal and glial properties coexist in a novel mouse CNS immortalized cell line. Experimental Cell Research, 252, 383-391.
33. Watkins, J., Basu, S., & Bogenhagen, D. F. (2008). A quantitative proteomic analysis of mitochondrial participation in p19 cell neuronal differentiation. Journal of Proteome Research, 7, 328-338.
34. Au, C. E., Bell, A. W., Gilchrist, A., Hiding, J., Nilsson, T., & Bergeron, J. J. (2007). Organellar proteomics to create the cell map. Current Opinion in Cell Biology, 19, 376-385.
35. Li, K. W., & Smit, A. B. (2008). Subcellular proteomics in neuroscience. Frontiers in Bioscience, 13, 4416-4425.
36. Blondeau, F., Ritter, B., Allaire, P. D., et al. (2004). Tandem MS analysis of brain clathrin-coated vesicles reveals their critical involvement in synaptic vesicle recycling. Proceedings of the National Academy of Sciences of the United States of America, 101, 3833-3838.
37. Coughenour, H. D., Spaulding, R. S., & Thompson, C. M. (2004). The synaptic vesicle proteome: A comparative study in membrane protein identification. Proteomics, 4, 3141-3155.
38. Li, K. W. (2007). Proteomics of synapse. Analytical and Bioanalytical Chemistry, 387, 25-28.
39. Huttner, W. B., Schiebler, W., Greengard, P., & De Camilli, P. (1983). Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. Journal of Cell Biology, 96, 1374-1388.
40. Hartinger, J., Stenius, K., Hogemann, D., & Jahn, R. (1996). 16-BAC/SDS-PAGE: A two-dimensional gel electrophoresis system suitable for the separation of integral membrane proteins. Analytical Biochemistry, 240, 126-133.
41. Burre, J., Zimmermann, H., & Volknandt, W. (2007). Immunoisolation and subfractionation of synaptic vesicle proteins. Analytical Biochemistry, 362, 172-181.
42. Witzmann, F. A., Arnold, R. J., Bai, F., et al. (2005). A proteomic survey of rat cerebral cortical synaptosomes. Proteomics, 5, 2177-2201.
43. Schrimpf, S. P., Meskenaite, V., Brunner, E., et al. (2005). Proteomic analysis of synaptosomes using isotope-coded affinity tags and mass spectrometry. Proteomics, 5, 2531-2541.
44. Godovac-Zimmermann, J., & Brown, L. R. (2001). Perspectives for mass spectrometry and functional proteomics. Mass Spectrometry Reviews, 20, 1-57.
45. Kriegsheim, A., Preisinger, C., & Kolch, W. (2008). Mapping of signaling pathways by functional interaction proteomics. Methods in Molecular Biology, 484, 177-192.
46. Colucci-D'Amato, L., Perrone-Capano, C., & di Porzio, U. (2003). Chronic activation of ERK and neurodegenerative diseases. Bioessays, 25, 1085-1095.
47. Dowell, J. A., Johnson, J. A., & Li, L. (2009). Identification of astrocyte secreted proteins with a combination of shotgun proteomics and bioinformatics. Journal of Proteome Research, 8, 4135-4143.
48. Schubert, D., Herrera, F., Cumming, R., et al. (2009). Neural cells secrete a unique repertoire of proteins. Journal of Neurochemistry, 109, 427-435.
49. Mor-Vaknin, N., Punturieri, A., Sitwala, K., & Markovitz, D. M. (2003). Vimentin is secreted by activated macrophages. Nature Cell Biology, 5, 59-63.
50. Tytell, M. (2005). Release of heat shock proteins (Hsps) and the effects of extracellular Hsps on neural cells and tissues. International Journal of Hyperthermia, 21, 445-455.
51. Johnson, M. D., Yu, L. R., Conrads, T. P., et al. (2005). The proteomics of neurodegeneration. American Journal of Pharmacogenomics, 5, 259-270.
52. Sun, F., & Cavalli, V. (2009). Neuroproteomics: Towards understanding neuronal regeneration and degeneration. Molecular & Cellular Proteomics.
53. Perrin, R. J., Fagan, A. M., & Holtzman, D. M. (2009). Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature, 461, 916-922.
54. Zetterberg, H., Ruetschi, U., Portelius, E., et al. (2008). Clinical proteomics in neurodegenerative disorders. Acta Neurologica Scandinavica, 118, 1-11.
55. Han, M. H., Hwang, S. I., Roy, D. B., et al. (2008). Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature, 451, 1076-1081.
56. Noorbakhsh, F., Overall, C. M., & Power, C. (2009). Deciphering complex mechanisms in neurodegenerative diseases: The advent of systems biology. Trends in Neurosciences, 32, 88-100.
57. Wilkins, M. R., Pasquali, C., Appel, R. D., et al. (1996). From proteins to proteomes: Large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (N Y), 14, 61-65.
58. Gorg, A., Boguth, G., Obermaier, C., Posch, A., & Weiss, W. (1995). Two-dimensional polyacrylamide gel electrophoresis with immobilized pH gradients in the first dimension (IPG-Dalt): The state of the art and the controversy of vertical versus horizontal systems. Electrophoresis, 16, 1079-1086.
59. Gorg, A., Drews, O., Luck, C., Weiland, F., & Weiss, W. (2009). 2-DE with IPGs. Electrophoresis, 30(Suppl 1), S122-S132.
60. Altland, K., Becher, P., Rossmann, U., & Bjellqvist, B. (1988). Isoelectric focusing of basic proteins: The problem of oxidation of cysteines. Electrophoresis, 9, 474-485.
61. Smejkal, G. B. (2006). The promise of gel-based proteomics. Expert Opinion on Drug Discovery, 1, 7-10.
62. Vercauteren, F. G., Arckens, L., & Quirion, R. (2007). Applications and current challenges of proteomic approaches, focusing on two-dimensional electrophoresis. Amino Acids, 33, 405-414.
63. Pearce, A., & Svendsen, C. N. (1999). Characterisation of stem cell expression using two-dimensional electrophoresis. Electrophoresis, 20, 969-970.
64. Romeo, M. J., Espina, V., Lowenthal, M., Espina, B. H., Petricoin, E. F., 3rd, & Liotta, L. A. (2005). CSF proteome: A protein repository for potential biomarker identification. Expert Review of Proteomics, 2, 57-70.
65. Unlu, M., Morgan, M. E., & Minden, J. S. (1997). Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis, 18, 2071-2077.
66. Barthéléry, M., Jaishankar, A., Salli, U., Freeman, W. M., & Vrana, K. E. (2009). 2-D DIGE identification of differentially expressed heterogeneous nuclear ribonucleoproteins and transcription factors during neural differentiation of human embryonic stem cells. Proteomics Clinical Applications, 3, 505-514.
67. Schirle, M., Heurtier, M. A., & Kuster, B. (2003). Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometry. Molecular & Cellular Proteomics, 2, 1297-1305.
68. Burre, J., Beckhaus, T., Schagger, H., et al. (2006). Analysis of the synaptic vesicle proteome using three gel-based protein separation techniques. Proteomics, 6, 6250-6262.
69. Takamori, S., Holt, M., Stenius, K., et al. (2006). Molecular anatomy of a trafficking organelle. Cell, 127, 831-846.
70. Henzel, W. J., Billeci, T. M., Stults, J. T., Wong, S. C., Grimley, C., & Watanabe, C. (1993). Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proceedings of the National Academy of Sciences of the United States of America, 90, 5011-5015.
71. Ishii, D., Hibi, K., Asai, K., Nagaya, M., Mochizuki, K., & Mochida, Y. (1978). Studies of microhigh-performance liquid chromatography. IV. Application of the micro pre-column method to the analysis of corticosteroids in serum. Journal of Chromatography, 156, 173-180.
72. Tsuda, T., & Novotny, M. V. (1978). Packed microcapillary columns in high performance liquid chromatography. Analytical Chemistry, 50, 271-275.
73. Scott, R. P., & Kucera, P. (1979). Use of microbore columns for the separation of substances of biological origin. Journal of Chromatography, 185, 27-41.
74. Tomer, K. B., Moseley, M. A., Deterding, L. J., & Parker, C. E. (1994). Capillary liquid chromatography/mass spectrometry. Mass Spectrometry Reviews, 13, 431-457.
75. Vissers, J. P. (1999). Recent developments in microcolumn liquid chromatography. Journal of Chromatography A, 856, 117-143.
76. Shen, Y., Zhao, R., Berger, S. J., Anderson, G. A., Rodriguez, N., & Smith, R. D. (2002). High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Analytical Chemistry, 74, 4235-4249.
77. Gatlin, C. L., Kleemann, G. R., Hays, L. G., Link, A. J., & Yates, J. R., 3rd. (1998). Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry. Analytical Biochemistry, 263, 93-101.
78. Martin, S. E., Shabanowitz, J., Hunt, D. F., & Marto, J. A. (2000). Subfemtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI fourier transform ion cyclotron resonance mass spectrometry. Analytical Chemistry, 72, 4266-4274.
79. Domon, B., & Aebersold, R. (2006). Mass spectrometry and protein analysis. Science, 312, 212-217.
80. Bantscheff, M., Schirle, M., Sweetman, G., Rick, J., & Kuster, B. (2007). Quantitative mass spectrometry in proteomics: A critical review. Analytical and Bioanalytical Chemistry, 389, 1017-1031.
81. America, A. H., & Cordewener, J. H. (2008). Comparative LC-MS: A landscape of peaks and valleys. Proteomics, 8, 731-749.
82. Gevaert, K., Impens, F., Ghesquiere, B., van Damme, P., Lambrechts, A., & Vandekerckhove, J. (2008). Stable isotopic labeling in proteomics. Proteomics, 8, 4873-4885.
83. Oda, Y., Huang, K., Cross, F. R., Cowburn, D., & Chait, B. T. (1999). Accurate quantitation of protein expression and site-specific phosphorylation. Proceedings of the National Academy of Sciences of the United States of America, 96, 6591-6596.
84. Ong, S. E., Blagoev, B., Kratchmarova, I., et al. (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Molecular & Cellular Proteomics, 1, 376-386.
85. Bendall, S. C., Hughes, C., Stewart, M. H., Doble, B., Bhatia, M., & Lajoie, G. A. (2008). Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Molecular & Cellular Proteomics, 7, 1587-1597.
86. Prokhorova, T. A., Rigbolt, K. T., Johansen, P. T., et al. (2009). Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Molecular & Cellular Proteomics, 8, 959-970.
87. Graumann, J., Hubner, N. C., Kim, J. B., et al. (2008). Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5, 111 proteins. Molecular & Cellular Proteomics, 7, 672-683.
88. Steiniger, S. C., Coppinger, J. A., Kruger, J. A., Yates, J., 3rd, & Janda, K. D. (2008). Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population. Stem Cells, 26, 3037-3046.
89. Orlando, R., Lim, J. M., Atwood, J. A., 3rd, et al. (2009). IDAWG: Metabolic incorporation of stable isotope labels for quantitative glycomics of cultured cells. Journal of Proteome Research, 8, 3816-3823.
90. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., & Aebersold, R. (1999). Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnology, 17, 994-999.
91. Schmidt, A., Kellermann, J., & Lottspeich, F. (2005). A novel strategy for quantitative proteomics using isotope-coded protein labels. Proteomics, 5, 4-15.
92. Ramus, C., Gonzalez de Peredo, A., Dahout, C., Gallagher, M., & Garin, J. (2006). An optimized strategy for ICAT quantification of membrane proteins. Molecular & Cellular Proteomics, 5, 68-78.
93. Tian, Q., Stepaniants, S. B., Mao, M., et al. (2004). Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Molecular & Cellular Proteomics, 3, 960-969.
94. Prahalad, A. K., & Hock, J. M. (2009). Proteomic characteristics of ex vivo-enriched adult human bone marrow mononuclear cells in continuous perfusion cultures. Journal of Proteome Research, 8, 2079-2089.
95. Ross, P. L., Huang, Y. N., Marchese, J. N., et al. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Molecular & Cellular Proteomics, 3, 1154-1169.
96. Ow, S. Y., Salim, M., Noirel, J., Evans, C., Rehman, I., & Wright, P. C. (2009). iTRAQ underestimation in simple and complex mixtures: "The good, the bad and the ugly". Journal of Proteome Research, 8, 5347-5355.
97. Richardson, K., Denny, R., Hughes, C., et al. (2010). A probabilistic framework for peptide and protein quantification. submitted for publication.
98. Thompson, A., Schafer, J., Kuhn, K., et al. (2003). Tandem mass tags: A novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Analytical Chemistry, 75, 1895-1904.
99. Unwin, R. D., Smith, D. L., Blinco, D., et al. (2006). Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. Blood, 107, 4687-4694.
100. Griffiths, S. D., Burthem, J., Unwin, R. D., et al. (2007). The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia. Molecular Biotechnology, 36, 81-89.
101. Lund, T. C., Anderson, L. B., McCullar, V., et al. (2007). iTRAQ is a useful method to screen for membrane-bound proteins differentially expressed in human natural killer cell types. Journal of Proteome Research, 6, 644-653.
102. Seshi, B. (2006). An integrated approach to mapping the proteome of the human bone marrow stromal cell. Proteomics, 6, 5169-5182.
103. Salim, K., Kehoe, L., Minkoff, M. S., Bilsland, J. G., Munoz-Sanjuan, I., & Guest, P. C. (2006). Identification of differentiating neural progenitor cell markers using shotgun isobaric tagging mass spectrometry. Stem Cells and Development, 15, 461-470.
104. Bondarenko, P. V., Chelius, D., & Shaler, T. A. (2002). Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Analytical Chemistry, 74, 4741-4749.
105. Chelius, D., & Bondarenko, P. V. (2002). Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. Journal of Proteome Research, 1, 317-323.
106. Wang, W., Zhou, H., Lin, H., et al. (2003). Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Analytical Chemistry, 75, 4818-4826.
107. Silva, J. C., Denny, R., Dorschel, C. A., et al. (2005). Quantitative proteomic analysis by accurate mass retention time pairs. Analytical Chemistry, 77, 2187-2200.
108. Ishihama, Y., Oda, Y., Tabata, T., et al. (2005). Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Molecular & Cellular Proteomics, 4, 1265-1272.
109. Lu, P., Vogel, C., Wang, R., Yao, X., & Marcotte, E. M. (2007). Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nature Biotechnology, 25, 117-124.
110. Silva, J. C., Gorenstein, M. V., Li, G. Z., Vissers, J. P., & Geromanos, S. J. (2006). Absolute quantification of proteins by LCMSE: A virtue of parallel MS acquisition. Molecular & Cellular Proteomics, 5, 144-156.
111. Vissers, J. P., Langridge, J. I., & Aerts, J. M. (2007). Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Molecular & Cellular Proteomics, 6, 755-766.
112. Rower, C., Vissers, J. P., Koy, C., et al. (2009). Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue. Analytical and Bioanalytical Chemistry, 395, 2443-2456.
113. Malmstrom, J., Beck, M., Schmidt, A., Lange, V., Deutsch, E. W., & Aebersold, R. (2009). Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature, 460, 762-765.
114. van Hoof, D., Passier, R., Ward-van Oostwaard, D., et al. (2006). A quest for human and mouse embryonic stem cell-specific proteins. Molecular & Cellular Proteomics, 5, 1261-1273.
115. Chambery, A., Vissers, J. P., Langridge, J. I., et al. (2009). Qualitative and quantitative proteomic profiling of cripto(-/-) embryonic stem cells by means of accurate mass LC-MS analysis. Journal of Proteome Research, 8, 1047-1058.
116. Anderson, L., & Hunter, C. L. (2006). Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Molecular & Cellular Proteomics, 5, 573-588.
117. Keshishian, H., Addona, T., Burgess, M., Kuhn, E., & Carr, S. A. (2007). Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Molecular & Cellular Proteomics, 6, 2212-2229.
118. Kuhn, E., Wu, J., Karl, J., Liao, H., Zolg, W., & Guild, B. (2004). Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics, 4, 1175-1186.
119. Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., & Gygi, S. P. (2003). Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proceedings of the National Academy of Sciences of the United States of America, 100, 6940-6945.
120. Pratt, J. M., Simpson, D. M., Doherty, M. K., Rivers, J., Gaskell, S. J., & Beynon, R. J. (2006). Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nature Protocols, 1, 1029-1043.
121. Anderson, N. L., Jackson, A., Smith, D., Hardie, D., Borchers, C., & Pearson, T. W. (2009). SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device. Molecular & Cellular Proteomics, 8, 995-1005.
122. Duncan, M. W., Yergey, A. L., & Patterson, S. D. (2009). Quantifying proteins by mass spectrometry: The selectivity of SRM is only part of the problem. Proteomics, 9, 1124-1127.
123. Sherman, J., McKay, M. J., Ashman, K., & Molloy, M. P. (2009). How specific is my SRM? The issue of precursor and product ion redundancy. Proteomics, 9, 1120-1123.
124. Hoopmann, M. R., Finney, G. L., & MacCoss, M. J. (2007). High-speed data reduction, feature detection, and MS/MS spectrum quality assessment of shotgun proteomics data sets using high-resolution mass spectrometry. Analytical Chemistry, 79, 5620-5632.
125. Luethy, R., Kessner, D. E., Katz, J. E., et al. (2008). Precursor-ion mass re-estimation improves peptide identification on hybrid instruments. Journal of Proteome Research, 7, 4031-4039.
126. Geromanos, S. J., Vissers, J. P., Silva, J. C., et al. (2009). The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics, 9, 1683-1695.
127. Limentani, G. B., Ringo, M. C., Ye, F., Berquist, M. L., & McSorley, E. O. (2005). Beyond the t-test: Statistical equivalence testing. Analytical Chemistry, 77, 221A-226A.